BIO VIEW (Israel) Profile

Performance

   

Odds of Distress

Check how we calculate scores
Equity ratings for BIO VIEW are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting June 19, 2019 and ending today August 18, 2019. Click here to learn more.
BioView Ltd. develops, manufactures, and markets automated cell imaging and analysis solutions for use in cytology, cytogenetic, and pathology clinical and research laboratories in Israel and internationally. The company was founded in 2000 and is headquartered in Rehovot, Israel. BIO VIEW is traded on Tel Aviv Stock Exchange in Israel. more
NameBIO VIEW
Co-CEO, DirectorYuval HarariView All
Thematic Classification
Currently Active Investing Idea
  Investor Favorites
View All
Macroaxis Advice
InstrumentIsrael Stock View All
Business Address3 Pekeris Street
ExchangeTel Aviv Stock Exchange
SectorHealthcare
IndustryMedical Devices
BenchmarkDOW
Websitewww.bioview.com
Phone972 73 227 1025
CurrencyILS - Israeli Shekel
Next Fiscal Year EndDecember 31, 2020
Most Recent QuarterMarch 31, 2019
Last Fiscal Year EndDecember 31, 2018

BIO VIEW Corporate Directors

Eliane Markowitz External Director
Yacha Sutton Director
Jackie RosenblumGoren External Director
Check also Trending Equities. Please also try Equity Valuation module to check real value of public entities based on technical and fundamental data.
Search macroaxis.com